- Home
- ULBI vs SCPH Comparison
ULBI vs SCPH Comparison
Compare ULBI & SCPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ULBI
- SCPH
- Stock Information
- Founded
- ULBI 1990
- SCPH 2013
- Country
- ULBI United States
- SCPH United States
- Employees
- ULBI N/A
- SCPH N/A
- Industry
- ULBI Industrial Machinery/Components
- SCPH Biotechnology: Pharmaceutical Preparations
- Sector
- ULBI Miscellaneous
- SCPH Health Care
- Exchange
- ULBI Nasdaq
- SCPH Nasdaq
- Market Cap
- ULBI 174.9M
- SCPH 163.3M
- IPO Year
- ULBI 1992
- SCPH 2017
- Fundamental
- Price
- ULBI $9.43
- SCPH $5.40
- Analyst Decision
- ULBI Strong Buy
- SCPH Strong Buy
- Analyst Count
- ULBI 1
- SCPH 2
- Target Price
- ULBI $14.00
- SCPH $19.00
- AVG Volume (30 Days)
- ULBI 46.4K
- SCPH 258.3K
- Earning Date
- ULBI 10-24-2024
- SCPH 11-06-2024
- Dividend Yield
- ULBI N/A
- SCPH N/A
- EPS Growth
- ULBI 283.01
- SCPH N/A
- EPS
- ULBI 0.60
- SCPH N/A
- Revenue
- ULBI $168,946,000.00
- SCPH $24,048,000.00
- Revenue This Year
- ULBI $10.59
- SCPH $195.62
- Revenue Next Year
- ULBI $8.72
- SCPH $145.07
- P/E Ratio
- ULBI $15.70
- SCPH N/A
- Revenue Growth
- ULBI 17.37
- SCPH 549.77
- 52 Week Low
- ULBI $6.36
- SCPH $3.24
- 52 Week High
- ULBI $13.39
- SCPH $7.55
- Technical
- Relative Strength Index (RSI)
- ULBI 43.86
- SCPH 60.05
- Support Level
- ULBI $9.07
- SCPH $4.97
- Resistance Level
- ULBI $9.77
- SCPH $5.40
- Average True Range (ATR)
- ULBI 0.43
- SCPH 0.23
- MACD
- ULBI -0.06
- SCPH 0.00
- Stochastic Oscillator
- ULBI 25.73
- SCPH 91.38
About ULBI Ultralife Corporation
Ultralife Corp provides products and services ranging from power solutions to communications and electronics systems to customers across the globe in the government and defense, medical, safety and security, energy, and industrial sectors. The company designs, manufactures, installs, and maintains power and communications systems including rechargeable and non-rechargeable batteries, charging systems, communications and electronics systems and accessories, and custom-engineered systems. The company's segments include Battery and Energy Products, and Communications Systems. It generates maximum revenue from the Battery and Energy Products segment, and from the U.S. The Battery & Energy Products segment includes Lithium 9-volt, cylindrical, and various other non-rechargeable batteries.
About SCPH scPharmaceuticals Inc.
scPharmaceuticals Inc is a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care and reduce healthcare costs. The company's main product is Furoscix. Furoscix consists of this patented formulation of furosemide for subcutaneous administration with wearable, portable sc2Wear Infusor for the treatment of edema in patients with heart failure.